NCT02746302View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

May 31, 2014

Conditions
Healthy
Interventions
DRUG

HS-20004

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY